Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 71 for “"neoadjuvant therapy"”.

  1. Automatic Cellularity Assessment in Surgical Specimens After Neoadjuvant Therapy of Breast Cancer

    … tumor cellularity in surgical specimens after neoadjuvant chemotherapy for breast cancer. At present pathological examination of the tissue sections after surgery is the gold-standard to estimate the residual tumor. Currently, tumor cellularity is manually estimated by pathologists from …

    toronto-retro Repository record for Automatic Cellularity Assessment in Surgical Specimens After Neoadjuvant Therapy of Breast Cancer (opens in a new tab)

  2. Economic Evaluation of Total Neoadjuvant Therapy and Watch and Wait in Rectal Cancer

    … and multi-modal treatments such as radiotherapy, chemotherapy, and surgery. Despite these treatments and often very morbid surgeries, traditional management still results in high rates of distant metastasis, which directly impacts patient survival prospects and quality of life (QoL), and …

    adelaide Repository record for Economic Evaluation of Total Neoadjuvant Therapy and Watch and Wait in Rectal Cancer (opens in a new tab)

  3. Prediction of Pre-Operative Local Staging and Optimising Treatment Response to Neoadjuvant Therapy in Colorectal Cancer.

    … about the risk vs benefit of chemotherapy can be made reliably. Patients with advanced rectal cancer are commonly referred for neoadjuvant therapy as part of standard care treatment protocols based on Magnetic Resonance Imaging (MRI) local staging. Following neoadjuvant therapy, …

    adelaide Repository record for Prediction of Pre-Operative Local Staging and Optimising Treatment Response to Neoadjuvant Therapy in Colorectal Cancer. (opens in a new tab)

  4. The Performance of Circulating Biomarkers in the Prediction of Response to Neoadjuvant Therapy in Patients with Oesophago-gastric Cancer

    … beyond 5 years after diagnosis. The addition of neoadjuvant therapy has been shown to increase survival in patients suitable for curative surgery. However, the additional gains are modest and the majority of patients do not respond sufficiently from therapy to gain any benefit. There is an urgent …

    plymouth Repository record for The Performance of Circulating Biomarkers in the Prediction of Response to Neoadjuvant Therapy in Patients with Oesophago-gastric Cancer (opens in a new tab)

  5. The use of prognostic factors to identify the group of beneficiaries for secondary resection in patients with primarily not-resectable pancreatic adenocarcinoma

    … patients regularly receive palliative chemotherapy. However, current studies show a benefit of neoadjuvant intended therapy and subsequent secondary resection for some patients. This investigation aimed to find factors that help identify patients with a good prognosis to justify an …

    fu-berlin Repository record for The use of prognostic factors to identify the group of beneficiaries for secondary resection in patients with primarily not-resectable pancreatic adenocarcinoma (opens in a new tab)

  6. Statistical Approaches to Identifying Therapeutic Vulnerabilities from Cancer Genomics Data

    … of cancers due to cancer cells’ resistance to therapy. There is a significant challenge in identifying which patients will benefit from targeted therapies and matching the correct therapy to each patient. This demonstrates the need for a comprehensive statistical analysis of genomic alterations …

    rice Repository record for Statistical Approaches to Identifying Therapeutic Vulnerabilities from Cancer Genomics Data (opens in a new tab)

  7. Tumor- und risikoadaptierte Individualisierung der neoadjuvanten und post-neoadjuvanten Therapie bei PatientInnen mit Mammakarzinom

    … decade, modern oncology has switched from a “one therapy fits all” to a risk-tailored and individualized medicine. For breast cancer, the most common malignancy in women worldwide, this has led to early breast cancer nowadays being seen as a curable disease. A great benefit of modern diagnostic …

    lmu-germany Repository record for Tumor- und risikoadaptierte Individualisierung der neoadjuvanten und post-neoadjuvanten Therapie bei PatientInnen mit Mammakarzinom (opens in a new tab)

  8. Accuracy of multidetector-row CT for restaging after neoadjuvant treatment in patients with oesophageal cancer

    … of patients with oesophageal cancer undergoing neoadjuvant therapy. METHODS: Results of pathological staging were correlated with those from 64-MDCT before and after neoadjuvant treatment in 35 patients using the American Joint Committee on Cancer/TNM classification (7th edition). CT response …

    zurich Repository record for Accuracy of multidetector-row CT for restaging after neoadjuvant treatment in patients with oesophageal cancer (opens in a new tab)

  9. Longitudinal T cell receptor repertoire analysis in immunotherapy of HER2-positive breast cancer

    … the receptor HER2, are treated using neoadjuvant immunochemotherapy containing anti-HER2 antibodies. T cells are immune cells identified by a T cell receptor, which is capable of highly specific binding to antigenic peptides presented by major histocompatibility complex proteins, and …

    cau-kiel Repository record for Longitudinal T cell receptor repertoire analysis in immunotherapy of HER2-positive breast cancer (opens in a new tab)

  10. Enhancing the neoadjuvant treatment of rectal cancer by targeting the Inhibitor of Apoptosis Proteins

    Total neoadjuvant therapy (TNT) has emerged as a standard approach for locally advanced rectal cancer, combining (chemo)radiation and systemic chemotherapy prior to surgery. This strategy improves tumour downstaging, increasing the likelihood of non-operative management, and reduces local and …

    qu-belfast Repository record for Enhancing the neoadjuvant treatment of rectal cancer by targeting the Inhibitor of Apoptosis Proteins (opens in a new tab) Embargoed until 2027-07-31

  11. Outcomes Following Resection for Esophageal Cancer in Ontario

    … patients at thoracic centres received more neoadjuvant therapy, had similar margin rates and lymph node harvest, experienced lower postoperative mortality, and had similar overall survival. Across thoracic centres, neoadjuvant therapy use varied from 16.4-81.6%, positive margin rates varied …

    toronto-retro Repository record for Outcomes Following Resection for Esophageal Cancer in Ontario (opens in a new tab)

  12. Unveiling the Molecular Features of Cancer Health Differences Through Multi-Omics Data Analysis

    … between complete and incomplete responders to Neoadjuvant therapy in rectal cancer. In chapter 2, the content focuses on investigating the molecular characterizations of 14 cancer types with different body fat. We identify molecular alterations and pathways associated with overweight/obesity …

    uab Repository record for Unveiling the Molecular Features of Cancer Health Differences Through Multi-Omics Data Analysis (opens in a new tab)

  13. RNA HELICASE, DP103 AS A PREDICTIVE BIOMARKER FOR DOCETAXEL RESPONSE IN ERa-POSITIVE BREAST CANCER

    … PHASE II STUDY INVOLVING DOCETAXEL BASED NEOADJUVANT THERAPY, CLINICAL RESPONDERS WERE CHARACTERIZED BY A PROGRESSIVE DECREASE IN DP103 EXPRESSION. THIS DECREASE IN DP103 EXPRESSION WAS ONLY OBSERVED IN RESPONDERS WITH ERA-POSITIVE STATUS AND NOT ERA-NEGATIVE STATUS. DEPLETION OF DP103 …

    nus Repository record for RNA HELICASE, DP103 AS A PREDICTIVE BIOMARKER FOR DOCETAXEL RESPONSE IN ERa-POSITIVE BREAST CANCER (opens in a new tab) Download file for RNA HELICASE, DP103 AS A PREDICTIVE BIOMARKER FOR DOCETAXEL RESPONSE IN ERa-POSITIVE BREAST CANCER (opens in a new tab)

  14. Refining tumor response in rectal cancer: the role of tumor budding

    … innovative approaches to evaluate response to neoadjuvant therapy in colorectal cancer, focusing on tumor budding (TB) as a predictive biomarker. We examined TB and tumor-infiltrating lymphocytes (TILs) as opposing forces in the tumor microenvironment, emphasizing their prognostic significance. …

    radboud Repository record for Refining tumor response in rectal cancer: the role of tumor budding (opens in a new tab) Download PDF for Refining tumor response in rectal cancer: the role of tumor budding (opens in a new tab)

  15. A Convolutional Neural Network Approach to Breast Cancer Tumor Boundary Detection

    … diagnosed with breast cancer and undergoing neoadjuvant therapy. For training, image masks were generated as ground truths using signal enhancement ratio segmentation, thresholding, and contour detection. The effectiveness of two lightweight models, with and without batch normalization and …

    calpoly Repository record for A Convolutional Neural Network Approach to Breast Cancer Tumor Boundary Detection (opens in a new tab)

Page 1 of 4